Cutler Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,400
Closed -$17K 5085
2020
Q1
$17K Sell
2,400
-3,400
-59% -$564K ﹤0.01% 2427
2019
Q4
$37K Buy
+5,800
New +$1.08M ﹤0.01% 1842
2019
Q3
Sell
-500
Closed -$70K 4904
2019
Q2
$70K Hold
500
0.01% 1310
2019
Q1
$59K Buy
+500
New +$166K 0.01% 1323
2018
Q4
Sell
-700
Closed -$1K 4814
2018
Q3
$1K Sell
700
-200
-22% -$78.8K ﹤0.01% 3939
2018
Q2
$4K Sell
900
-1,100
-55% -$399K ﹤0.01% 3301
2018
Q1
$4K Sell
2,000
-300
-13% -$76K ﹤0.01% 3482
2017
Q4
$21K Buy
2,300
+500
+28% +$93.4K ﹤0.01% 2533
2017
Q3
$3K Buy
1,800
+300
+20% +$45.4K ﹤0.01% 4913
2017
Q2
$11K Buy
1,500
+200
+15% +$26.9K ﹤0.01% 4104
2017
Q1
$2K Sell
1,300
-10,900
-89% -$1.26M ﹤0.01% 5619
2016
Q4
$87K Sell
12,200
-4,900
-29% -$568K ﹤0.01% 2035
2016
Q3
$64K Buy
17,100
+13,100
+328% +$1.57M ﹤0.01% 2218
2016
Q2
$6K Sell
4,000
-1,600
-29% -$159K ﹤0.01% 4809
2016
Q1
$12K Buy
5,600
+900
+19% +$76K ﹤0.01% 3892
2015
Q4
$40K Buy
+4,700
New +$399K ﹤0.01% 2707

Other funds holding ABMD

Cutler Group's ABMD Position: Q1 2020 in Review

Cutler Group sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 1,900 shares — an estimated $315K sold.

Cutler Group first reported a position in ABMD in Q4 2015 and held it in 10 quarters. The position peaked at $1.02M in Q1 2016. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Cutler Group reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 1,900 Abiomed Inc shares in Q1 2020, an estimated $315K.
  • Cutler Group first reported a position in Abiomed Inc in Q4 2015 and held it in 10 quarters.
  • Cutler Group's Abiomed Inc position peaked at $1.02M in Q1 2016.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.